This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
healthcare: Archive
UnitedHealth Reaffirms 2025 EPS Guidance: Time to Buy or Wait?
by Kaibalya Pravo Dey
UNH reaffirms its 2025 EPS outlook, but mounting costs, legal probes and valuation pressures cloud the path ahead.
UNHNegative Net Change BRK.BPositive Net Change MOHNegative Net Change CNCNegative Net Change
earnings-outlook healthcare hmo insurance medical
Investing in the Age of Longevity: Silver Economy Stocks in Focus
by Urmimala Biswas
AbbVie, Amgen, Stryker and Dexcom are tapping into the booming silver economy with new therapies, tech and acquisitions aimed at aging populations.
ABTNegative Net Change AMGNNegative Net Change MDTNegative Net Change SYKNegative Net Change DXCMNegative Net Change ABBVNegative Net Change
biotechnology biotechs healthcare medical medical-devices robotics
Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now?
by Urmimala Biswas
BFLY trades at distressed levels with analyst targets signaling sharp upside, while TEM's premium valuation tempers its appeal.
AZNNegative Net Change NVDANegative Net Change BFLYNegative Net Change TEMNegative Net Change
artificial-intelligence earnings-outlook earnings-report earnings-surprise healthcare medical medical-devices smart-health
Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?
by Urmimala Biswas
Tempus AI's soaring Q2 revenues, margin gains and near-EBITDA breakeven position it as a fast-rising force in precision medicine.
IRTCNegative Net Change SOPHNegative Net Change TEMNegative Net Change
artificial-intelligence earnings-outlook earnings-report earnings-surprise healthcare medical medical-devices
When a Healthcare Giant Gets Sick: Elevance Health's 20% YTD Decline
by Kaibalya Pravo Dey
ELV's 20% YTD slump reflects shrinking memberships, rising costs and deepening analyst pessimism despite long-term growth levers.
UNHNegative Net Change CNCNegative Net Change ELVNegative Net Change
earnings-outlook healthcare hmo insurance insurance-premium medical
Is CVS a Smart Buy Now on Strong Q2, Low Valuation & Long-Term Upside?
by Urmimala Biswas
CVS appears well-poised on strong Q2 revenue growth, raised full-year guidance and momentum in key healthcare segments.
UNHNegative Net Change CVSNegative Net Change HLFNegative Net Change
earnings-estimates-revisions earnings-outlook earnings-preview earnings-report earnings-surprise healthcare medical medical-devices
UnitedHealth Crashing After Q2 Shock: Should You Panic or Pounce?
by Kaibalya Pravo Dey
UNH plunges 12.9% after weak Q2 and slashing 2025 EPS guidance, sparking fears of deeper structural issues ahead.
UNHNegative Net Change MOHNegative Net Change CNCNegative Net Change
earnings-outlook earnings-surprise healthcare hmo insurance medical
Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?
by Urmimala Biswas
TEM surged 34.5% in Q2 on AI-driven deals and product momentum, but valuation and profit concerns linger ahead of earnings.
AZNNegative Net Change TXGNegative Net Change SOPHNegative Net Change TEMNegative Net Change
artificial-intelligence earnings-estimates-revisions earnings-outlook earnings-preview earnings-report earnings-streak earnings-surprise healthcare medical medical-devices smart-health
Tempus AI or NVIDIA: Which is the Smarter Bet in AI-Backed Healthcare?
by Urmimala Biswas
Tempus AI surges 91.8% YTD with soaring genomics revenues and a $200M AstraZeneca deal, outpacing NVIDIA in AI healthcare gains.
AZNNegative Net Change NVONegative Net Change NVDANegative Net Change TEMNegative Net Change
artificial-intelligence healthcare medical medical-devices smart-health tech-stocks
CVS or UnitedHealth: Which Stock Is a Better Buy Ahead of Q2 Earnings?
by Urmimala Biswas
CVS shows resilience with stable insurance margins and capital discipline, while UNH faces cost headwinds and a sharp earnings cut.
UNHNegative Net Change CVSNegative Net Change
earnings-estimates-revisions earnings-outlook earnings-preview earnings-report healthcare medical medical-devices retail